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Introduction: Mesenchymal cells are emerging as a promising cell platform for regenerative therapies. However,
the fate of cells after transplantation in many different disease settings and tissue beds remains unclear.
Methods: In this study, human adipose-derived stromal/stem (ASCs) cells were fluorescently labeled with a
membrane dye and injected into both immunocompetent and immunocompromised mouse strains. Cells were
injected either as single cell suspensions, or as self-assembling spheroids. In parallel, cells were purposefully
devitalized prior to injection and then implanted in the opposite side in a randomized fashion. These ‘control’
groups were included to determine whether the fluorescent membrane dye would remain localized at the injection
site despite the use of nonviable cells. Cell implants and the surrounding tissues were harvested on days 3, 10 and
21 after in vivo delivery and evaluated in a blinded manner. Injection sites were analyzed by fluorescent microscopy,
and human cell numbers were quantified using PCR detection of a human-specific endogenous retrovirus (ERV-3).
Host response was evaluated by immunofluorescent staining of macrophages.
Results: ERV-3 quantification showed that 95% of the human cells that were viable when they were injected were
undetectable at the three-week time-point. Although fluorescent signal persisted for the entire study period, further
analysis revealed that much of this signal was located within host macrophages.
Conclusions: These results suggest that human ASCs survive for less than three weeks after injection into even
immunocompromised mice, and call into question the notion that human ASCs are immuno-privileged and
capable of surviving for extended periods in xenogeneic and/or allogeneic models.Introduction
As the promise of cell-based therapies begins to transi-
tion to the clinic, a clear understanding of the survival,
localization and identity of administered cells over time
remains elusive but of great interest. A major limitation
relates to various technical challenges associated with
the reliable identification and tracking of cells in vivo.
Even in the context of preclinical animal models, the
sensitive and specific identification of human cells after* Correspondence: hiteshdos@hotmail.com
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unless otherwise stated.implantation presents certain challenges. Although a
number of methods have been described, most – if not
all – should be re-evaluated in the context of recent
findings related to cell-derived vesicles, or microparti-
cles [1,2]. These elements encompass a heterogeneous
spectrum of membrane-bound structures ranging in
size from 20 nm to 1 μm, released by an ever-expanding
list of cell types, and containing DNA, RNA, and cyto-
solic and/or membrane-associated proteins [2]. The no-
tion that such microvesicles may play a role in the false
positive contamination of host cells by labeled donor
cells has been reported recently in the literature [3].
A variety of literature suggests that human adipose-
derived stromal/stem cells (ASCs) are immunotolerant/
immunoprivileged and can survive for prolonged periodsl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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animals [4-7]. In this study we investigated the survival
of human ASCs in both immunocompetent and immuno-
compromised murine models, delivered either as single-
cell suspensions or as self-assembled three-dimensional
spheroids. The extent of human cell engraftment was
quantified over time using PCR detection of an endogen-
ous retrovirus (ERV-3) present in all human cells, but not
present in rodent cells. Since the ERV-3 genetic sequence
is present as only a single copy per human cell, its de-
tection is directly proportional to the number of human
cells present. Using this sensitive and specific method
of human cell detection, we demonstrate that nearly
90% of human ASCs that were viable upon injection
are undetectable by day 10 after administration into
nude mice. Human cell clearance is even faster in im-
munocompetent animals.
Materials and methods
Isolation and culture expansion of human
adipose-derived stromal/stem cells
Human adipose tissue samples were obtained from elect-
ive surgical procedures under Institutional Review Board
approval at the University of Virginia. We obtained all
necessary consent from any patients involved in the study.
ASCs were isolated as described previously [8,9]. Briefly,
samples were washed, enzymatically dissociated with
Liberase Blendzyme (Roche Applied Science, Indianapolis,
USA), and filtered to remove debris [9]. After centrifuga-
tion, pelleted cells were recovered and washed. Contamin-
ating erythrocytes were removed by osmotic buffer, and
the cells were plated onto tissue culture plastic and culture
expanded in adherent monolayer culture in xenogeneic-
free growth medium with 1% human serum (LM1%) [10].
After three passages, culture-expanded ASCs were mem-
brane dye (DiI) labeled according to the manufacturer’s
protocol (Molecular Probes, Inc., Eugene, OR, USA).
Some labeled cells were formed into self-assembling
spheroids in hanging drop [11,12]. Mouse embryonic
fibroblast cells (3 T6) were obtained from University of
Virginia cell culture core facility and were cultured in
Dulbecco’s modified Eagle’s medium/F12 high glucose
with 10% fetal bovine serum.
DiI labeling of adipose-derived stromal/stem cells
ASCs were suspended at a density of 1 × 106/ml in
culture medium. Five microliters of DiI cell labeling
solution were added to the cell suspension, followed by
gentle mixing with a pipette. The mixture was incu-
bated at 37°C for 20 minutes. Next, the labeled suspen-
sion tubes were centrifuged at 1,500 rpm/200 × g force
for 5 minutes at 37°C. This was followed by removal of
supernatant and resuspension of the cells in Dulbecco’s
modified Eagle’s medium/F12 high glucose with 10%fetal bovine serum at 37°C. This washing procedure was
repeated two more times.
Adipose-derived stromal/stem cell implantation into mice
Procedures were performed with approval of the University
of Virginia Animal Care and Use Committee. Two strains
of mice were used. Thirty-six immunocompetent wildtype
(C57BL/6NCr) mice and 36 immunocompromised (Athy-
mic NCr-nu/nu) mice were anaesthetized using ketamine
and randomly treated with 300,000 cells either in suspen-
sion or preaggregated into spheroids (10 spheroids each
comprised of 30,000 cells), followed by appropriate postop-
erative pain control. Cells delivered as suspensions were
injected subcutaneously and into the inguinal region, while
cells formulated as three-dimensional spheroids were deliv-
ered through an incision into the inguinal fat pad of mice.
Implants composed of nonviable cells/spheroids served as
parallel controls, implanted in the contralateral side in a
randomized, blinded fashion. Nonviable cell implants
were generated by overnight incubation at −80°C, thaw-
ing at room temperature and confirmed as nonviable
with trypan blue dye exclusion and Cell Proliferation
Reagent WST-1 (Roche Applied Science).
Harvesting and processing of tissues
Three sets of mice (each set comprising 12 immuno-
competent mice and 12 immunocompromised mice)
were harvested on days 3, 10 and 21 after implantation.
Through random sampling, one-half of the mice from
each harvest time point were assigned to be used for
histology and one-half of the mice for human cell quan-
tification by PCR detection of ERV-3. The histology
specimens were fixed in 10% neutral buffered formalin
and were embedded in paraffin while the PCR samples
were frozen at −80°C.
Quantification of human adipose-derived stromal/stem
cells
Real-time PCR detection of the human/primate-specific
ERV-3 was used to evaluate and quantify the presence of
human ASCs. Of note, the ERV-3 gene is known to reside
at a single locus (on human chromosome 7), enabling a
direct correlation between ERV-3 levels and human cell
numbers [13]. The primers for the human specific ERV-3
gene were designed as described previously [14,15]: for-
ward, 5-ATG GGA AGC AAG GGA ACT AAT G;
reverse, 5-CCC AGC GAG CAA TAC AGA ATT T
(Integrated DNA Technologies, Coralville, Iowa, USA).
Preserved samples from injection sites were frozen with
liquid nitrogen and ground to powder using a mortar
and pestle. DNA extraction was performed with DNAzol
(Molecular Research Centre, Cincinnati, Ohio, USA) ac-
cording to the manufacturer’s protocol. DNA extract from
cultured ASCs served as a positive control (that is, ASCs
Figure 1 Standard sample of cells mixture analyzed using
real-time PCR. Ct, cycle threshold.
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used as a negative control (that is, ASCs 0%).
Standards were prepared by combining cultured hu-
man ASCs and mouse embryonic fibroblast cells (3 T6)
in known ratios (ASCs 4.76%, 0.498%, 0.05%, and 0.005%).
Accordingly, standards were generated from the mixture
of defined numbers (5 × 104, 5 × 103, 5 × 102 and 5 × 10) of
human ASCs with 106 mouse embryonic fibroblast cells.
Genomic DNA was extracted from these preparations ac-
cording to experimental protocol. Real-time quantitative
PCR with 96-well optical plates was performed and ana-
lyzed using an icycler iQ (BioRad, Hercules, CA, USA).
Each reaction was performed using 4.5 μl DNA specimen
added to 8 μl PCR reagent mixture comprised of SYBR
green and forward and reverse primers. Extracted DNA
was assessed for quality and quantity using GeneQuant
Pro (Amersham Biosciences, Piscataway, NJ, USA) and
each sample was run at 1:10 and 1:50 dilutions in dupli-
cate. The PCR conditions used were: first step, 95°C for
15 minutes; and second step, 45 cycles each with 30 sec-
onds at 95°C (denaturation), 30 seconds at 60°C (an-
nealing) and 30 seconds at 72°C (extension). The
threshold cycle (CT) was defined as the first cycle num-
ber in a PCR amplification above baseline and during the
exponential increase period, with 40 as the maximum al-
lowable value. Appropriate amplification was deter-
mined by melt curve analysis, with an ERV-3 melting
temperature of 87.5°C.
For generation of a standard curve, six defined mix-
tures/ratios of human ASCs and mouse embryonic fib-
roblast cells (3 T6) were analyzed. The amplification
curves and CT values obtained are presented in Table 1.
Log[human ASCs] linearly correlated with CT values,
with a correlation coefficient of 0.97 (Figure 1). From
these results, an equation depicting the relationship be-
tween CT values and human ASCs was obtained as
follows:
Human ASC number ¼ 10– CT– 39:5ð Þ=3:03Table 1 Real-time PCR results
Mouse 3 T6 cells Human ASCs Human ASC % CT (n = 6) STD
1,000,000 50,000 4.760 24.6 0.3884
1,000,000 5,000 0.498 29.2 0.2566
1,000,000 500 0.050 31.6 0.3536
1,000,000 50 0.005 33.9 0.0707
1,000,000 0 0 NA NA
0 50,000 100 24.2 0.2887
Real-time PCR results for single-cell suspension mixtures used to create a
standardized curve. ASC, adipose-derived stromal/stem cell; CT, cycle threshold;
NA, not available; STD, = Standard Deviation.Histology and immunohistochemistry
Tissue sections were stained with hematoxylin and
eosin, and representative sections were prepared for
immunohistochemical staining by deparaffinization with
xylene and rehydration through a graded ethanol series. A
heat-mediated antigen retrieval technique that included
a 20-minute boil in 0.01 M citrate buffer, pH 6.0 (Fisher
Scientific, Waltham, MA, USA) was used. After cooling
for 1 hour, two separate 5-minute washes in Tris-buffered
saline/Tween20 pH 7.4 (Trizma base; Sigma; Tween20; J.
T. Baker, St Louis, MO, USA), followed by two 5-minute
washes in phosphate-buffered saline were performed. The
sections were incubated in 2% horse serum (Sigma,
Austin, TX, USA) prepared in phosphate-buffered saline
with 0.5% gelatin from cold water fish skin, to inhibit non-
specific binding of the primary antibody. Following incu-
bation in blocking serum, the sections were incubated in
primary antibody rat anti-mouse Mac-2 (Cedarlane,
Burlington, ON, Canada), dilution 1:1,000, in a humidified
chamber for 1 hour. Following this, two 5-minute washes
in 0.5% gelatin from cold water fish skin/phosphate-buff-
ered saline were performed. The sections were then
incubated in secondary antibody Alexa Fluor 488 donkey
anti-rat (Invitrogen, Carlsbad, CA, USA) for 1 hour in a
humidified chamber at room temperature. This was
followed by three 5-minute washes in phosphate-buffered
saline, prior to aqueous mounting (Fisher Scientific).
The immunostained slides were imaged using a con-
focal Nikon Eclipse TE 2000-E2 microscope (Nikon,
Melville, NY, USA) equipped with a 60× Nikon oil
immersion objective
Statistical analysis
The percentage of ERV-3 was obtained with real-time
PCR as the fraction of ERV-3 remaining at the implant-
ation site on days 3, 10 and 21. Data were analyzed using
SPSS 19.0 (IBM Corp. Released 2010. IBM SPSS Statis-
tics for Windows, Version 19.0. Armonk, NY, USA).
Using an independent-samples t test, we compared the
Table 2 Survival of adipose-derived stromal/stem cells
Immunocompetent mice Immunocompromised mice
% ERV-3 Viable injection Nonviable injection Viable injection Nonviable injection
Spheroids Cells Spheroids Cells Spheroids Cells Spheroids Cells
Day 3 (n = 3) 57.5 ± 3.9 55.6 ± 14.7 0.9 ± 0.8 0 90.6 ± 8.2 87.6 ± 6.8 0.1 ± 0.03 0.9 ± 0.3
Day 10 (n = 3) 7.1 ± 3.0 0 0 0 11.7 ± 0.8 12.1 ± 1.3 0 0
Day 21 (n = 3) 0 0 0 0 4.8 ± 0.6 6.3 ± 0.9 0 0
Percent survival of adipose-derived stromal/stem cells (% ERV-3) measured with real-time PCR. Values represent mean ± standard error of n = 3. ERV-3, endogenous
retrovirus 3.
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pension versus spheroids for different time points (days
3, 10 and 21), separately for the two murine species. We
also compared the percent ERV-3 between immuno-
competent mice versus immunocompromised mice for
the time points studied.
Results
Animal survival
All mice survived the surgical procedure of cell im-
plantation. Out of 72 treated animals, 71 survived to ex-
perimental endpoint. One athymic NCr-nu/nu mouse
injected with spheroids died on day 7.
PCR for adipose-derived stromal/stem cell presence and
quantification
Real-time PCR was performed using ERV-3 amplifi-
cation to assess human cell presence in harvested
tissue specimens from injection/implantation sites. TheFigure 2 Graphical representation of adipose-derived stromal/stem ce
immunocompromised mice. Error bars represent ± 1 standard error of n =persistence of human ASCs is correlated to the percent
ERV-3 amplification [13-15], and our study shows that
when viable ASCs are injected in vivo, an increased per-
centage of cells can be detected relative to nonviable
ASC implants, regardless of formulation (cell suspension
versus spheroids). As expected, the number of detectable
ASCs implanted as either cell suspension or spheroids
was greater in immunocompromised mice at all time
points as compared with immunocompetent mice, with
statistically significant differences on days 10 and 21
after implantation (P <0.05). However, there were no
statistical differences in the PCR detection of ASCs over
time when implanted as cell suspension compared with
those implanted as three-dimensional spheroids (Table 2,
Figure 2).
Histology and immunohistochemistry
On gross observation, the DiI-labeled implants were
readily identifiable as pink blushes at the implantationll persistence (% ERV-3) in immunocompetent mice versus
3. ERV-3, endogenous retrovirus 3.
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tensity subjectively waned with later time points. Using
fluorescent microscopy, the DiI-labeled human adipose-
derived cell implants were readily visible as a fluorescent
signal that was localized to the region of implantation
for the entire 3-week study period. The fluorescent signal
was easily detectable with a high signal-to-noise ratio. The
fluorescent signal arising from nonviable cell implants was
indistinguishable from that arising from viable cell im-
plants (Figures 3 and 4). Detection of human cells using
highly specific PCR-mediated methods showed that <1%
of implanted nonviable cells were detectable at the im-
plantation site on day 3 despite the presence of a robust
fluorescent signal for up to 3 weeks. On the other hand,
up to 90% of implanted viable cells were detectable by
PCR on day 3, but this rapidly declined to <5% by day 21,
once again despite the presence of a robust fluorescent
signal. In all cases, the implanted cells were noted toFigure 3 Immunocompetent mice injected with adipose-derived strom
days 3, 10 and 21 are represented in different rows. First column, photogra
column, hematoxylin and eosin (H & E)-stained sections; third column, fluo
200 μm. ASC, adipose-derived stromal/stem cell.generate a robust macrophage infiltrate, seen with Mac-2
immunostaining that co-localized with the DiI fluorescent
signal (Figures 5 and 6).
Discussion
A variety of cell-based therapies stand at the threshold
of changing the way medicine is practiced. A growing
body of evidence now suggests that cell therapies act pri-
marily via paracrine effects [16,17]. However, questions
remain unanswered as to how many cells are needed and
how long such cells are needed at a given site in order to
effect a reproducible response. To answer these questions,
reliable quantitative methods are required that are both
specific and sensitive. In other words, one of several im-
portant issues related to the future understanding and
translation of such therapies to the clinic pertains to quan-
tifying and optimizing cell survival and biodistribution
after cell delivery. This challenge remains critical even foral/stem cells in suspension and in spheroids. Tissues harvested on
phs on gross inspection (arrows indicate injection sites); second
rescent images of same sections. Scale bar on lower right corner:
Figure 4 Immunocompromised mice injected with adipose-derived stromal/stem cells in suspension and in spheroids. Tissues harvested
on days 3, 10 and 21 are represented in different rows. First column, photographs on gross inspection (arrows indicate injection sites); second
column, hematoxylin and eosin (H & E)-stained sections; third column, fluorescent images of same sections. Scale bar on lower right corner:
200 μm. ASC, adipose-derived stromal/stem cell.
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the safety and efficacy of emerging therapies.
Given the growing interest in exploiting adipose tis-
sue as an abundant cell source, our objective was to
evaluate human ASC persistence after implantation into
immunocompetent and immunocompromised mice using
fluorescent membrane labeling techniques for histological
tracking, and PCR detection of human-specific genetic se-
quences for confirmatory and quantitative analysis. Both
sensitive and specific, real-time PCR for ERV-3 detects as
few as 50 human cells in 1,000,000 murine cells (0.005%)
[14,15], compared with detection of 5,000 cells/organ re-
ported in green fluorescent protein studies [18]. ERV-3 is
present in the human genome as only one copy per cell,
on chromosome 7 [13,14]. As such, ERV-3 can be used to
detect and quantify the presence of human cells, and do
so without need for cellular manipulation. However, it
does not provide histological or morphological data. Ourdata show that <1% of nonviable ASCs implanted were de-
tectable by PCR detection of ERV-3, 72 hours after im-
plantation. Although detection of ERV-3 does not give a
direct confirmation of cell viability, it is conceivable that a
close correlation does exist between cell viability and the
ability to detect a specific DNA sequence with PCR. It is
known, for example, that large DNA fragmentation occurs
as early as 5 minutes after the onset of apoptosis. Further
breakdown into smaller fragments continues over 2 to
24 hours [19,20].
Based on our PCR data, it appears that human ASCs
are cleared quite rapidly in the murine strains used in
this study, with clearance in immunocompetent mice oc-
curring faster than in immunocompromised mice. More
specifically, nearly 90% of cells that were viable at injec-
tion are undetectable by day 10, and only 5% are detect-
able at the implant site at 21 days. It is possible that a
majority of the cells migrate away from the injection site
Figure 5 Immunocompetent mice injected with live and nonviable adipose-derived stromal/stem cell spheroid. Top row:
immunocompetent mice injected with live adipose-derived stromal/stem cell (ASC) spheroids harvested on day 3. First column, images with DiI
membrane dye (red); second column, sections with Mac-2 stain (Alexa 488; green); third column, images with 4′,6-diamidino-2-phenylindole (DAPI;
blue); fourth column, merged fluorescent images of the same sections. Middle row: Immunocompetent mice injected with live and nonviable
adipose-derived stromal/stem cell spheroids and harvested on day 3. Bottom row: non-injected control tissue from immunocompetent mice.
Scale bars: 50 μm.
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cent (DiI) signal that is visible at the implantation sites
(Figures 3, 4 and 7) argues strongly against this possibility.
Somewhat surprisingly, human cell clearance also ap-
pears to be rapid in the immunocompromised Athymic
NCr-nu/nu mouse model, raising concern for suitability
of this strain for xenogeneic studies. The rapid undetect-
ability of human cells in vivo is associated with a robust
infiltration of host macrophages – even in the athymic
mouse. Although mature T cells are missing in athymic
mice, the B cells, dendritic cells and granulocytes are all
relatively intact, and there is a compensatory increase in
macrophages and natural killer cell activity [21]. The co-
localization of Mac-2 staining with fluorescent DiI label/
signal suggests strongly that ASC implantation stimulates
a rapid and robust macrophage infiltrate which correlates
with decreasing (human) cell numbers as measured by
ERV-3 quantification (Table 2). Indeed, our results show
that a significant amount of DiI signal is located within
Mac-2 stained macrophages (Figures 5 and 6). The DiI
fluorescent signal remained visible throughout the entirety
of our study time period; however, it appears that human
ASC-related dye transfer and/or persistence can occur in
the context of macrophage-mediated phagocytosis ofhuman cells [22,23], via the exchange of membrane mi-
crodomains [3], and/or via microvesicle and/or exosome
[2,24] transfer. It is possible that the fluorescent DiI
stain is itself immunogenic and may accelerate the en-
gulfment of human cells. There could also be tissue-
specific and/or species-specific differences in the macro-
phage response to implanted cells. In this study, we
injected human ASCs subcutaneously and into the in-
guinal fat pad. Adipose tissue is known to contain resident
macrophages and can also efficiently recruit additional
macrophages when inflammatory stimuli arise [25-27].
It is conceivable that in other tissues the time course or
extent of this phenomenon may look different. In
addition to tissue-specific responses, it is unclear
whether our findings would be similar in other im-
munocompromised murine models, such as the nonob-
ese diabetic/severe combined immunodeficiency mouse
model. Both of these variables deserve further
interrogation.
This study also compared the persistence of human
ASCs delivered as single-cell suspensions versus three-
dimensional spheroids. Contrary to our original hypo-
thesis, this study did not demonstrate any statistical
difference in the persistence of ASCs formulated and
Figure 7 Non-injected control tissues seen on gross inspection, hematoxylin and eosin stain and fluorescent microscopy. Top row:
immunocompetent mice. Bottom row: immunocompromised mice. H & E, hematoxylin and eosin.
Figure 6 Immunocompromised mice injected with live and nonviable adipose-derived stromal/stem cell suspensions. Top row:
immunocompromised mice injected with live adipose-derived stromal/stem cell (ASC) cell suspensions harvested on day 3. First column, images
with DiI dye (red); second column, sections with Mac-2 stain (Alexa 488; green); third column, images with DAPI 4′,6-diamidino-2-phenylindole
(DAPI; blue); fourth column, merged fluorescent images of the same sections. Middle row: nonviable ASC cell suspensions injected into
immunocompromised mice and harvested on day 3. Bottom row: non-injected control tissue from immunocompromised mice. Scale bars: 50 μm.
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Table 3 Previous studies of implanted cell persistence and migration in vivo
Reference Species of donor and recipient Method and site of delivery Cell labeling method Findings
[4] Donor, human ASCs; Recipient, SCID
mice
5 × 106cells injected intramyocardially
in the peri-infarct region
Transduction with luciferase, GFP 10 weeks: 10% of the human ASCs were localized at the
site of injection for 10 weeks. No migration detected. 3.5%
differentiated into cardiomyocytes or endothelial cells.
[3] Donor, human HL60 cells; recipient,
NOD/SCID mice
Intravenous injection of 20 × 106 cells
stained with DIR. Rest of the cell labeling
techniques were studied in vitro
Lipophilic dyes: DiI, DiD, DiR, PKH26 2 weeks: lipophilic dyes lead to rapid contamination of
neighboring cells. CFSE showed good biocompatibility
and staining efficiency and showed little contamination.
DDAO was toxic to cells. Quantum dots provided
heterogeneous staining that is not suitable for intravital
microscopy (IVM). IRDye 800CW had suboptimal excitation
by the 633 nm lasers used for IVM in this study
Amine reactive dye: CFSE, DDAO-SE
Nano crystals: quantum dots 70S
Antibodies: IRDye 800CW
[30] Donor, porcine ASCs; recipient, Pigs Subcutaneous implantation of cells seeded
in collagen scaffold
BrdU labeling 4 weeks: BrdU-labeled ASCs were present but no quantifi-
cation was done
[31] Donor, MCF7 human breast cancer cells,
human cord blood-derived cells, human
NeoHep cells, human hepatopancreatic
precursors; recipient, NOD/SCID mice
Injection into left lobe of liver, 7.5 × 105 human
NeoHep or cord blood cells; tail vein injection,
5 × 106 MCF7 cells; intrapancreatic injection,
5 × 105 hepatopancreatic precursor cells;
intracardiac transplantation, 5 × 105
hepatopancreatic precursor cells
DiI and red fluorescent
nanoparticles Qdot655
3 weeks: FISH for human-specific Alu sequence and
mouse major satellite showed that though many of
DiI-labeled cells were human in origin, some were
phagocytosed by murine cells. Qdot655 faded
during the FISH procedure.
[6] Donor, human ASCs; recipient, BALB/C
nu/nu mice
5 × 106cells injected i.m. or i.v. Transduction with luciferase 75% of cells were lost in first week, the remainder were
stable for up to 32 weeks
[28] Donor, sheep MSCs; recipient,
Merino-cross sheep
Intramuscular injection DiI labeling and CFSE DiI-labeled MSCs showed dye retention for 6 weeks. CFSE
showed rapid signal loss over 8 days
[32] Donor, human ASCs; recipient, BALB/C
nu/nu mice
106 cells injected i.m., s.c., i.v., i.p. or enclosed
in a fibrin matrix
Lipofection and electroporation
with luciferase, GFP
3 weeks: cells migrated and accumulated at the ventral
side. A higher fibrinogen concentration limited cell
mobility in the fibrin matrix
ASC, adipose-derived stromal/stem cell; CFSE, carboxyfluorescein succinimidyl ester; FISH, fluorescent in situ hybridization; GFP, green fluorescent protein; i.m., intramuscularly; i.p., intraperitoneally; i.v., intravenously;
















Table 4 Comparison of contemporary cell tracking methods
Tracking method – mechanism Disadvantages Advantages
GFP, luciferase – DNA transfer can be mediated
virally (transduction), via liposomes (lipofection),
or by electrical parameters (electroporation/
transfection)
- Genetic manipulation of cells may alter their
function
- Human ASCs with GFP or luciferase
resume proliferation normally
- Since they are cytosolic in location; the vector
(mRNA/DNA) and/or the protein (GFP) could be
transmitted to host cells via fusion elements and/
or microvesicle secretion, resulting in
contamination. Hence, there is concern for false
positivity and their detection may not equate to
viability of donor cells
- Detection is sensitive to in vivo non-
invasive bioluminescence imaging
- Technique requires serial passages, not suitable for
use with fresh uncultured cells
- Many mammalian tissues have endogenous
fluorescence
BrdU – this nuclear marker is a thymidine analog
that replaces (3H) thymidine and can penetrate
cell membranes to incorporate into newly
synthesized DNA strands of actively proliferating
cells
- Optimal labeling requires longer incubation time - BrdU labeling has no effects on the ASC
differentiation/proliferation and is not
cytotoxic- Not suitable for non-invasive methods of detection
- Does not indicate viability
- Cells lose BrdU rapidly with serial passages
Lipophilic dyes (DiI, DiR) –long-chain
carbocyanine dyes with long aliphatic tails that
incorporate into the lipid regions of the cell
membranes
- Rapidly contaminates neighboring cells by
macrophage-mediated phagocytosis, exchange of
membrane microdomains, microvesicle and/or
exosome transfer
- Easy technique for labeling and
identification of cells
- May be cytotoxic to cells
- The dye fades with serial passages
Amine reactive probes (CFSE) – these diffuse into
cells and react with cytosolic amine-containing
residues to form dye–protein adducts that are
retained
- The dye is toxic to ASCs - Good staining efficiency
- Not suitable for in vivo non-invasive imaging
- Does not correlate with viability
- Contamination of neighboring cells can occur via
macrophage-mediated phagocytosis, microvesicle
and/or exosome transfer
Nanoparticles – small crystals made up of
inorganic molecules; for example, iron oxide,
cadmium
- Can be toxic to cells in high concentration and
detection is difficult with low concentrations
- Photostable, remain resistant for long
periods of time
- Contamination of neighboring cells can occur via
phagocytosis, microvesicles and/or exosome
transfer
- Can be used for in vivo non-invasive
imaging
- Does not correlate with viability
Real-time PCR for endogenous retroviral
sequence (ERV-3) – the gene is present as a
single copy in the human genome and so can
be used to detect the presence of transplanted
human cells in animal models
- Not suitable for non-invasive methods of detection - Gives a quantitative estimate of number
of cells
- False positives can occur by macrophage-mediated
phagocytosis but this is very low
- Very sensitive and specific
- The gene is already present in the human
cells, so there is no need to stain the cells
FISH detection of human-specific cell surface
markers or Alu sequences
- Alu sequences occur in large numbers in the
primate genome, which makes higher likelihood of
a false positive detection by transmission to host
cells/macrophages via microvesicles/exosomes
- The gene is already present in the human
cells, so there is no need to stain the cells
- Not suitable for non-invasive methods of detection
- Does not correlate with viability
ASC, adipose-derived stromal/stem cell; BrdU, 5-Bromo-2-deoxyurudine; CFSE, carboxyfluorescein succinimidyl ester; ERV-3, endogenous retrovirus 3; FISH,
fluorescent in situ hybridization; GFP, green fluorescent protein.
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those delivered as cell suspensions. Three-dimensional
spheroid cultures are widely believed to better mimic
the in vivo condition. They exhibit a higher degree ofstructural complexity and homeostasis, analogous to tis-
sues and organs, including the presence of self-generated
extracellular matrix [11]. For these reasons, we believed
that cells delivered as spheroids would succumb less to
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lar cells delivered as a single-cell suspension. However, the
ERV-3 data do not support this hypothesis, perhaps be-
cause the macrophage infiltrate is similar regardless of the
implant formulation.
As summarized in Table 3, a wide variety of cell labe-
ling and tracking methods have been reported in the
literature. There is notable discrepancy in the findings of
these studies and direct comparison is difficult due to
differences in cell source/type, recipient species, cell
labeling method and concentration, cell dose, and cell
delivery method. For example, Lassailly and colleagues
report findings for lipophilic dyes (for example, DiI)
similar to ours, but find amine reactive dyes to be bio-
compatible and associated with little contamination [3].
Weir and colleagues, on the other hand, found that
amine reactive dyes displayed rapid signal loss over the
course of a week [28]. Vilalta and colleagues reported
the persistence of 25% of human ASCs in athymic mice
for up to 32 weeks using virally mediated transduction
of luciferase [6], and Bai and colleagues reported the
persistence of 10% of human ASCs in SCID mice using
a similar labeling method [4]. Although no single
method or technique of cell tracking has been proven
optimal, each method ought to be reconsidered in light
of the emerging literature on microvesicles, and mem-
brane fusion events.
Microvesicles are produced by most cells, including me-
senchymal stem cells and ASCs [1], and they can carry
and transmit RNA, DNA, cytosolic proteins, and cell
membrane proteins. Moreover, it is known that environ-
mental stressors can stimulate the release of microvesicles
from cells [29]. As such, cytosolic and membrane-bound
proteins such as luciferase and green fluorescent protein
can potentially be transmitted to host cells via fusion
events and/or microvesicle secretion, resulting in false
positive microenvironmental contamination. Similarly,
detection of human cell surface labels such as human
leukocyte antigen or of human-specific genetic sequences
such as Alu can also be a result of microvesicle-mediated
false positive contamination of the microenvironment.
Although it remains supposition at this point in time, it is
statistically plausible that the more prevalent a given
protein or genetic sequence is within a cell, the higher the
likelihood it will be transferred to a neighboring cell/
microenvironment via a microvesicle or similar mecha-
nism. By this logic, Alu elements – which are the most
abundant transposable elements in the human genome –
as well as cytosolic proteins such as green fluorescent pro-
tein and luciferase, are more likely to be transferred to
neighboring cells than is the single DNA copy per cell of
ERV-3. This assumption certainly requires further studies
to confirm or repute, but is worth consideration when
interpreting pertinent studies. A comparison of variouscell tracking methods, including their relative advantages
and disadvantages, is presented in Table 4.
Conclusion
In summary, these studies demonstrate that when hu-
man ASCs are implanted into the subcutaneous and in-
guinal fat tissue of mice, almost all cells are undetectable
within 3 weeks using sensitive and specific molecular
techniques. In contrast, a robust fluorescent signal from
commonly used membrane dyes is readily detectable by
microscopy – even from nonviable cell implants. The co-
localization of DiI signal with the MAC-2 stain revealed
that DiI is taken up by macrophages by phagocytosis and
perhaps other mechanisms of cell transfer. Although
clearance of ASCs occurred faster in immunocompetent
mice compared with immunocompromised mice, there
were no significant differences in the persistence of ASCs
delivered as cell suspensions versus those implanted as
spheroids. In short, with the emerging evidence of micro-
vesicle formation by ASCs and other modes of host cell
contamination, we propose that ERV-3 detection by PCR
is a useful method for detecting and quantifying the pres-
ence of human cells in xenogeneic models. Further studies
are needed to help delineate the advantages and limita-
tions of the various methods available for cell labeling,
tracking, identification, and quantification.
Abbreviations
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